Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparin for prevention of venous thromboembolism following total hip or knee replacement or hip repair

2006 ◽  
Author(s):  
Carlos A Salazar ◽  
German Malaga ◽  
Giuliana Malasquez
Keyword(s):  
Molecular Weight ◽  
Venous Thromboembolism ◽  
Knee Replacement ◽  
Vitamin K ◽  
Low Molecular Weight Heparin ◽  
Vitamin K Antagonists ◽  
Thrombin Inhibitors ◽  
Direct Thrombin Inhibitors ◽  
Low Molecular Weight ◽  
Total Hip

Long-Term Use of Different Doses of Low-Molecular-Weight Heparin Versus Vitamin K Antagonists in the Treatment of Venous Thromboembolism

2010 ◽  
Vol 24 (5) ◽  
pp. 628-639 ◽  
Author(s):  
A. Romera-Villegas ◽  
M.A. Cairols-Castellote ◽  
R. Vila-Coll ◽  
X. Martí-Mestre ◽  
E. Colomé ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Venous Thromboembolism ◽  
Vitamin K ◽  
Low Molecular Weight Heparin ◽  
Vitamin K Antagonists ◽  
Low Molecular Weight ◽  
Different Doses

Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

2018 ◽  
Vol 131 (4) ◽  
pp. 430-437 ◽  
Author(s):  
Chatree Chai-Adisaksopha ◽  
Alfonso Iorio ◽  
Mark A. Crowther ◽  
Javier de Miguel ◽  
Estuardo Salgado ◽  
...  
Keyword(s):  
Molecular Weight ◽  
Venous Thromboembolism ◽  
Cancer Patients ◽  
Vitamin K ◽  
Low Molecular Weight Heparin ◽  
Vitamin K Antagonists ◽  
Low Molecular Weight
Sign in / Sign up

Export Citation Format

Share Document